Trillium Ag
Todd Hauser is the Founder of Trillium Ag since February 2016 and the Chairman of Halo-Bio RNAi Therapeutics, Inc. since October 2008. Previously, Todd served as the Director of Research at Oligoengine from 2000 to January 2015.
This person is not in any teams
Trillium Ag
Trillium Ag is developing a portfolio of RNAi-based biologicals to improve crop protection, health and yield. Our product pipeline is based on the breakthrough RNAi trigger (MV-RNA, US Patent 9,200,276) and nanoparticles for transient or stable trait activation.